<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Functional neurological symptom disorder (conversion disorder) in adults: Clinical features, assessment, and comorbidity</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Functional neurological symptom disorder (conversion disorder) in adults: Clinical features, assessment, and comorbidity</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Functional neurological symptom disorder (conversion disorder) in adults: Clinical features, assessment, and comorbidity</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Jon Stone, FRCP, PhD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Michael Sharpe, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Joel Dimsdale, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">David Solomon, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jun 27, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H13157790"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Functional neurological symptom disorder (conversion disorder) is characterized by neurologic symptoms, such as weakness, abnormal movements, or nonepileptic seizures, which involve abnormal nervous system functioning rather than structural disease [<a href="#rid1">1</a>]. In addition, clinical findings on examination provide evidence of incompatibility between the symptoms and recognized neurologic disease. Nevertheless, the disorder causes distress and/or functional impairment, is common in clinical settings, and often has a poor prognosis [<a href="#rid2">2-5</a>].</p><p>This topic reviews the clinical features, assessment, and comorbidity of functional neurological symptom disorder. The terminology, diagnosis, differential diagnosis, epidemiology, pathogenesis, prognosis, and treatment are discussed separately, as are functional neurological symptom disorder with attacks or seizures (functional or psychogenic nonepileptic seizures) and functional neurological symptom disorder with abnormal movements (functional movement disorders).</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/14826.html" rel="external">"Functional neurological symptom disorder (conversion disorder) in adults: Terminology, diagnosis, and differential diagnosis"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/85764.html" rel="external">"Functional neurological symptom disorder (conversion disorder) in adults: Epidemiology, pathogenesis, and prognosis"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/85766.html" rel="external">"Functional neurological symptom disorder (conversion disorder) in adults: Treatment"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/2227.html" rel="external">"Psychogenic nonepileptic seizures: Etiology, clinical features, and diagnosis"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/14132.html" rel="external">"Functional movement disorders"</a>.)</p><p></p><p class="headingAnchor" id="H13158823"><span class="h1">CLINICAL FEATURES AND ASSESSMENT</span></p><p class="headingAnchor" id="H13158831"><span class="h2">General principles</span><span class="headingEndMark"> — </span>Functional neurological symptom disorder (conversion disorder) can present with [<a href="#rid6">6</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Nonepileptic seizures (see  <a class="medical medical_review" href="/d/html/2227.html" rel="external">"Psychogenic nonepileptic seizures: Etiology, clinical features, and diagnosis"</a>)</p><p class="bulletIndent1"><span class="glyph">●</span>Weakness and paralysis</p><p class="bulletIndent1"><span class="glyph">●</span>Movement disorders (see  <a class="medical medical_review" href="/d/html/14132.html" rel="external">"Functional movement disorders"</a>)</p><p class="bulletIndent1"><span class="glyph">●</span>Speech disturbances</p><p class="bulletIndent1"><span class="glyph">●</span>Globus sensation (see  <a class="medical medical_review" href="/d/html/2240.html" rel="external">"Globus sensation"</a>)</p><p class="bulletIndent1"><span class="glyph">●</span>Sensory complaints</p><p class="bulletIndent1"><span class="glyph">●</span>Visual symptoms</p><p class="bulletIndent1"><span class="glyph">●</span>Cognitive symptoms</p><p></p><p>These symptoms may be episodic or sustained, and acute or chronic [<a href="#rid7">7</a>].</p><p>Assessment of patients presenting with possible functional neurological symptom disorder includes a medical history, physical examination, and indicated laboratory tests, as well as a psychiatric history and mental status examination. Patients are encouraged to recount all previous medical encounters and psychiatric diagnoses. Obtaining prior medical records can help provide information about previous symptoms or problems that patients may have forgotten or not recognized as a functional disorder [<a href="#rid8">8</a>].</p><p>It is essential to look for neurologic and other general medical conditions, particularly early-stage diseases [<a href="#rid1">1,9,10</a>]. The clinical evaluation should emphasize diseases that explain the patient’s symptoms better than functional neurological symptom disorder, as well as diseases that are comorbid; among patients with nonepileptic seizures, approximately 10 to 20 percent also have epilepsy [<a href="#rid11">11</a>], and patients with multiple sclerosis may also have functional limb weakness [<a href="#rid12">12</a>].</p><p>Comorbid psychiatric disorders are often present (see <a class="local">'Psychiatric disorders'</a> below), but may be difficult to discern because patients focus upon physical symptoms rather than symptoms of depressive and anxiety disorders.</p><p>Avoid indirect and fragmentary discussions of the diagnosis during the assessment [<a href="#rid13">13</a>]. Instead, clinicians should understand that successfully presenting the diagnosis of functional neurological symptom disorder to patients is a fundamental aspect of treatment. (See  <a class="medical medical_review" href="/d/html/85766.html" rel="external">"Functional neurological symptom disorder (conversion disorder) in adults: Treatment", section on 'Presenting the diagnosis'</a>.)</p><p>Patients diagnosed with functional symptoms should be reevaluated periodically because in rare cases a general medical etiology may take years to become evident.</p><p class="headingAnchor" id="H13158838"><span class="h3">History</span><span class="headingEndMark"> — </span>Clinicians taking the history of patients with a possible diagnosis of functional neurological symptom disorder should ask about [<a href="#rid8">8,14</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>All current somatic symptoms</strong> – Making a complete list of the symptoms at the beginning of the assessment can prevent new symptoms from appearing later. It can also be therapeutic as patients may feel more understood and unburdened. We routinely ask about fatigue, pain, dizziness, sleep disturbance, and impaired memory and concentration if the patient does not volunteer these. After the list is complete, return to each symptom as necessary.</p><p></p><p class="bulletIndent1">Multiple current neurologic symptoms (mixed symptoms subtype of functional neurological symptom disorder [eg, motor and sensory symptoms]) are often found in functional neurological symptom disorder [<a href="#rid1">1,15</a>]. In a prospective study of 54 patients with functional neurological symptom disorder, mixed symptoms occurred in 35 percent [<a href="#rid16">16</a>], and a randomized trial of 127 patients with the disorder found that the mean number of functional symptoms was 2.5 [<a href="#rid17">17</a>].</p><p></p><p class="bulletIndent1">Patients with functional neurological symptom disorder often report a large number of current or prior physical symptoms, dissociative symptoms, or functional disorders (eg, irritable bowel syndrome, fibromyalgia, or chronic fatigue syndrome [also known as myalgic encephalomyelitis/chronic fatigue syndrome]), in addition to functional symptoms [<a href="#rid18">18-20</a>]. As an example, one prospective study found that the mean number of physical symptoms was greater in patients with functional weakness (n = 107) than patients with weakness due to recognizable neurologic disease (n = 46; nine versus five symptoms) [<a href="#rid21">21</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Circumstances at onset </strong>–<strong> </strong>Clinical features that are commonly observed at onset of functional symptoms include panic attacks, migraine headache, or pain, as well as physical injury. A systematic review of 132 observational studies of functional neurological symptom disorder (869 patients) found that immediately prior to onset, physical injury occurred in 37 percent [<a href="#rid22">22</a>]. Although subsequent studies are consistent with this finding [<a href="#rid23">23,24</a>], physical injury is not specific to functional neurological symptom disorder. In addition, both functional (psychogenic) nonepileptic seizures and functional motor symptoms may occur after general anesthesia [<a href="#rid25">25,26</a>].</p><p></p><p class="bulletIndent1">Onset of functional symptoms is often sudden. As an example, a prospective study of 107 patients with functional weakness found that sudden onset (≤6 hours to maximal onset) while awake occurred in 46 percent, or upon waking from sleep or general anesthesia in 15 percent [<a href="#rid25">25</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Dissociation</strong> – Dissociation in the form of depersonalization (feeling disconnected from oneself) or derealization (feeling detached from the environment) may be present in patients with functional neurological symptom disorder, particularly at onset of the disorder or in association with a nonepileptic seizure [<a href="#rid27">27,28</a>]. Patients may describe dissociative symptoms as feeling “outside of myself,” “spaced out,” “far away,” or “unreal.”</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Disability</strong> – Patients with functional neurological symptom disorder experience disability and distress that is comparable with patients with recognizable neurologic disease [<a href="#rid21">21,29</a>]. Asking “What is a typical day like?” or “Do you spend much time in bed or out of the house?” may be more informative than asking patients what they cannot do [<a href="#rid14">14</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Ideas, concerns, and expectations</strong> – Asking patients what they think may be causing their neurologic symptoms and what should be done to treat them enables clinicians to tailor their explanation of the diagnosis and rationale for treatment.</p><p></p><p class="bulletIndent1">Patients are frequently dissatisfied with exclusively psychologic explanations for their neurologic symptoms, and may be less likely to attribute their symptoms to psychologic factors [<a href="#rid29">29-31</a>]. In one prospective study (n = 153), the belief that stress was a possible cause of the illness occurred in fewer patients with functional weakness than patients with weakness due to recognizable neurologic disease (24 versus 56 percent) [<a href="#rid21">21</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Psychosocial functioning</strong> – The relationship between functional symptoms and psychosocial functioning is bidirectional (each can affect the other) [<a href="#rid14">14,29</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Family history</strong> – Illnesses in parents, siblings, and children are common in patients with functional neurological symptom disorder. As an example, one prospective study (n = 60) found that general medical disorders in first-degree relatives were more common among patients with functional neurological symptom disorder than patients with recognizable neurologic disease (80 versus 37 percent of patients) [<a href="#rid18">18</a>]. Psychiatric disorders were also more common in relatives of functional neurological symptom disorder patients. In addition, some studies have found that patients with functional neurological symptom disorder have a family history of functional neurological symptom disorder [<a href="#rid32">32</a>]. However, it is not established that patients with functional neurological symptom disorder mimic the symptoms of other individuals [<a href="#rid33">33</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Course of illness</strong> – Asking “When did you last feel well” is a useful way of determining when onset of functional symptoms occurred, particularly for patients who have been ill for several years. In addition, a large amount of information can be condensed by drawing a graph with time on the x axis, severity of symptoms on the y axis, and adding life events or treatments (<a class="graphic graphic_figure graphicRef88078" href="/d/graphic/88078.html" rel="external">figure 1</a>). The intensity of functional symptoms may fluctuate [<a href="#rid21">21</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Previous functional disorders and functional symptoms </strong>– Previous functional disorders such as irritable bowel syndrome or fibromyalgia, or prior functional symptoms, can be helpful as evidence of a patient’s vulnerability to functional neurological symptom disorder.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Prior clinical experiences</strong> – Patients may have experienced iatrogenic harm from a misdiagnosis of recognized neurologic disease, unnecessary tests or medication, and from feelings of powerlessness when a doctor appears not to know what is wrong with them [<a href="#rid30">30,31</a>]. Reports of feeling disbelieved and ensuing self-doubt about the veracity of one’s own symptoms is common [<a href="#rid31">31</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Recent psychological stressors</strong> – Although adverse life events are common in patients with functional symptoms [<a href="#rid18">18,34,35</a>], many patients do not have obvious life events and stressors. In addition, psychological factors are not specific to functional neurological symptom disorder and can be diagnostically misleading if given too much weight. (See  <a class="medical medical_review" href="/d/html/85764.html" rel="external">"Functional neurological symptom disorder (conversion disorder) in adults: Epidemiology, pathogenesis, and prognosis", section on 'Predisposing, precipitating, and perpetuating factors'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Symptoms of comorbid psychiatric disorders</strong> – We typically leave questions about feelings of depression and anxiety until the end of the assessment (unless the patient volunteers these symptoms). Patients may understandably become defensive if they think that their symptoms will be ascribed to a “mental disorder.” For many patients, attributing physical symptoms to a mental disorder is the same as suggesting that the symptoms are “fake.” It may thus be helpful to avoid using terms such as depression or anxiety and frame the questions in terms of the presenting symptoms. As an example, we may ask “Does your weakness ever make you feel down or frustrated?” instead of “Have you been feeling depressed?” Anxiety and dysphoria are often but not always present in patients with functional neurological symptom disorder [<a href="#rid3">3</a>]. (See <a class="local">'Psychiatric disorders'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Physical and sexual abuse</strong> – Questions about abuse or adverse experiences, like those for comorbid psychiatric disorders, are often best left to the end of the assessment or a follow-up visit. Patients may be more forthcoming after trust has been established during the preceding phases of the assessment. It is important to provide patients enough time to discuss the issue if they volunteer information about abuse; clinicians pressed for time will be better served by asking about abuse during a subsequent interview or leaving this to a different clinician [<a href="#rid8">8</a>].</p><p></p><p class="bulletIndent1">A prior history of childhood abuse or neglect is more common in patients with functional neurological symptom disorder than patients with neurologic disease and healthy controls [<a href="#rid35">35-37</a>]. However, it is not clear that a history of sexual abuse is more common in functional neurological symptom disorder than patients with other psychiatric disorders, and most patients with functional neurological symptom disorder have not experienced abuse or neglect. (See  <a class="medical medical_review" href="/d/html/85764.html" rel="external">"Functional neurological symptom disorder (conversion disorder) in adults: Epidemiology, pathogenesis, and prognosis", section on 'Predisposing, precipitating, and perpetuating factors'</a>.)</p><p></p><p>Other clinical features previously identified as specific to functional neurological symptom disorder include “la belle indifference” and a predominance of left-sided symptoms; however, the evidence indicates that these two features are not specific to patients with functional neurological symptom disorder [<a href="#rid21">21,38</a>].</p><p>La belle indifference, which refers to an incongruous lack of concern (indifference) about significant symptoms, has no validity in discriminating functional neurological symptom disorder from recognizable neurologic disease. In a systematic review of 11 prospective or retrospective studies, the median frequency of la belle indifference was comparable for patients with functional neurological symptom disorder (n = 356) and patients with defined neurologic disease (n = 157; 21 versus 29 percent) [<a href="#rid39">39</a>]. In our experience, la belle indifference often indicates that patients are trying to appear brave or cheerful in the presence of actual distress (to avoid receiving a psychiatric diagnosis such as depression), or may less often suggest factitious disorder [<a href="#rid21">21</a>].</p><p>Unilateral functional symptoms do not appear to be more common on one side of the body than the other. Although a meta-analysis of 90 observational studies (1139 patients with functional symptoms) found that left-sided symptoms occurred in more patients than right-sided symptoms (58 versus 42 percent), this finding appeared to be due to reporting bias [<a href="#rid38">38</a>]. A separate analysis was conducted in the 78 studies (553 patients) in which laterality was reported incidentally in the study text and did not appear in the title; a left-sided preponderance of symptoms was found in only 53 percent of patients.</p><p class="headingAnchor" id="H13158852"><span class="h3">Examination</span><span class="headingEndMark"> — </span>For patients who present with symptoms that may represent functional neurological symptom disorder, the principles of assessment are to look for evidence of [<a href="#rid1">1,8</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Inconsistency at different points in the examination (eg, a patient with no ankle plantar flexion while supine on the examination table is able to stand on tip toes). In addition, observing patients before and after the formal examination can be revealing. As an example, compare the patient’s gait entering and leaving the examination room, what occurs when patients take their clothes off and put them on, or what occurs when they retrieve something from their bag.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Incongruity between the symptoms and recognized disease, (ie, the symptoms do not conform to known anatomical pathways and physiologic mechanisms). As an example, a tubular visual field defect is inconsistent with the laws of optics and eye physiology. (See <a class="local">'Visual symptoms'</a> below.)</p><p></p><p>Thus, the diagnosis of functional neurological symptom disorder rests upon positive clinical findings, which are described below. (See <a class="local">'Weakness and paralysis'</a> below and <a class="local">'Sensory symptoms'</a> below.)</p><p>However, patients with recognizable neurologic disease may also display these positive findings, indicating the presence of functional disorder comorbidity (also called “functional overlay”) [<a href="#rid12">12,40</a>]. In addition, inconsistent signs may be produced consciously (as in factitious disorder or malingering).</p><p>Additional information about the medical evaluation for functional neurological symptom disorder is discussed separately in the context of somatic symptom disorder. (See  <a class="medical medical_review" href="/d/html/112997.html" rel="external">"Somatic symptom disorder: Assessment and diagnosis", section on 'Assessment'</a>.)</p><p class="headingAnchor" id="H13158866"><span class="h2">Subtypes of functional neurological symptom disorder</span><span class="headingEndMark"> — </span>The clinical features and assessment of each functional neurological symptom disorder subtype are described below, and are listed as follows from most to least common [<a href="#rid2">2</a>].</p><p class="headingAnchor" id="H13158873"><span class="h3">Nonepileptic seizures</span><span class="headingEndMark"> — </span>A variety of terms have been used to describe functional neurological symptom disorder with seizures, including psychogenic nonepileptic seizures/attacks, psychogenic seizures, nonepileptic seizures, functional seizures, or dissociative seizures/attacks. This condition is marked by apparent impaired or loss of consciousness with abnormal generalized limb shaking or sudden motionless unresponsiveness, and the lack of paroxysmal activity on electroencephalograms [<a href="#rid1">1</a>]. An example of a positive sign of functional neurological symptom disorder with seizures is closed eyes with resistance to opening. Psychogenic nonepileptic seizures are discussed separately. (See  <a class="medical medical_review" href="/d/html/2227.html" rel="external">"Psychogenic nonepileptic seizures: Etiology, clinical features, and diagnosis"</a>.)</p><p class="headingAnchor" id="H13158880"><span class="h3">Weakness and paralysis</span><span class="headingEndMark"> — </span>Weakness is common in patients with functional neurological symptom disorder; a randomized trial with 127 patients found that weakness occurred in 31 percent [<a href="#rid17">17</a>]. Patients often report a history of dropping things, or ”dragging” or sudden buckling of the affected leg. Unilateral, hemiparetic symptoms are most frequent, but weakness in just one limb or in both legs also occurs [<a href="#rid18">18,21</a>]. Patients commonly report that the affected limb doesn’t feel “part” of them or “belong” to them, which can be interpreted as a form of depersonalization. Other dissociative symptoms as well as panic attacks, physical injury to the affected limb, and pain are commonly associated with onset of functional weakness [<a href="#rid22">22,25,40</a>].</p><p>The key diagnostic finding in functional weakness or paralysis is that the deficit is inconsistent at different times in the examination [<a href="#rid21">21</a>]. Positive signs of functional weakness on physical examination include the following [<a href="#rid8">8,14,41</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Obvious inconsistencies – Examples include:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>No ankle plantar flexion while lying down, but the ability to stand on tip toes</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Inability to move arm during examination, but able to use arm to take something out of a bag or put shoes back on</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Hoover sign – The test is based upon the principle that the hip is extended when the contralateral hip is flexed against resistance [<a href="#rid42">42</a>]. In weakness due to functional neurological symptom disorder, hip extension is weak in the affected leg with the patient lying down supine or seated. This in itself is unusual in a disease process, but is common in functional limb weakness. Hoover sign (indicating functional neurological symptom disorder) occurs when hip extension in the affected leg returns to normal during contralateral hip flexion against resistance in the unaffected leg (<a class="graphic graphic_figure graphicRef88076" href="/d/graphic/88076.html" rel="external">figure 2</a> and <a class="graphic graphic_picture graphicRef88075" href="/d/graphic/88075.html" rel="external">picture 1</a>). Ask the patient to concentrate on their good leg when flexing it. However, pain may result in a false positive. Studies in acute and chronic cases of functional neurological symptom disorder with weakness or paralysis suggest reasonable sensitivity and specificity for Hoover sign [<a href="#rid21">21,43-45</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Hip abductor sign – Comparable with Hoover sign, when the hip abductor sign is positive, hip abduction weakness in the affected leg returns to normal during contralateral hip abduction against resistance in the unaffected [<a href="#rid46">46</a>]. However, pain may result in a false positive.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Cocontraction sign – Cocontraction is the simultaneous contraction of agonist and antagonist muscles. During muscle strength testing of the agonist (eg, the biceps) in patients with functional neurological symptom disorder, the clinician may be able to detect contraction of the antagonist (eg, the triceps) [<a href="#rid41">41,47</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Give-way or collapsing weakness – The patient is asked to exert force in a particular direction, and as the examiner lightly exerts force in the opposite direction, the examiner feels an abrupt decrease in resistance as the patient’s extremity gives way suddenly [<a href="#rid21">21</a>]. In weakness due to neurologic disease, give-way weakness is less common. However, give-way weakness is a soft sign of functional weakness; other causes of give-way weakness include chorea, pain, joint problems, and failure to understand instructions.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A delayed, slow, or jerky descent when the clinician positions the outstretched arm in front of the patient and then releases it.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A global or inverted pyramidal pattern of weakness in the legs (eg, extensors weaker than flexors) [<a href="#rid21">21</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Facial spasm due to excessive contraction of orbicularis oculus (sometimes associated with photophobia) may be mistaken for ptosis (facial weakness) [<a href="#rid48">48,49</a>]. In the lower face, excessive contraction of the platysma may pull the mouth down or the jaw to the ipsilateral side and be mistaken for facial weakness.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Drift without pronation sign – If patients with functional upper limb weakness are asked to hold their arms in the air with their palms facing upwards, fingers adducted, and eyes closed, the affected arm may drift downwards but without accompanying pronation commonly seen in patients with upper motor neuron lesions [<a href="#rid50">50</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Sternocleidomastoid test – Patients are asked to rotate their head against resistance [<a href="#rid45">45,51</a>]. In functional weakness, patients exhibit difficulty rotating to the affected side, whereas patients with recognizable neurologic disease less commonly manifest weakness.</p><p></p><p>One study of 20 patients and 20 controls found that Hoover sign, cocontraction sign, give-way weakness, and drift without pronation sign were the most reliable of these signs [<a href="#rid45">45</a>].</p><p class="headingAnchor" id="H13158887"><span class="h3">Abnormal movement</span><span class="headingEndMark"> — </span>Functional neurological symptom disorder with motor symptoms or deficits can manifest as movement disorders. There are several functional movement disorder syndromes that are based upon the presenting symptoms, including:</p><p class="bulletIndent1"><span class="glyph">●</span>Functional tremor</p><p class="bulletIndent1"><span class="glyph">●</span>Functional dystonia</p><p class="bulletIndent1"><span class="glyph">●</span>Functional gait disorder</p><p class="bulletIndent1"><span class="glyph">●</span>Functional myoclonus</p><p class="bulletIndent1"><span class="glyph">●</span>Functional Parkinsonism</p><p></p><p>Functional movement disorders, including their common clinical characteristics, the specific clinical features of each syndrome, and their management are discussed separately. (See  <a class="medical medical_review" href="/d/html/14132.html" rel="external">"Functional movement disorders"</a>.)</p><p class="headingAnchor" id="H13158894"><span class="h3">Speech symptoms</span><span class="headingEndMark"> — </span>The most common functional speech symptom is functional dysphonia, which usually presents as whispering or hoarseness, often after an episode of viral laryngitis has remitted [<a href="#rid52">52</a>]. Clues that the speech impairment is related to a functional disorder include the presence of a normal cough or singing voice. The diagnosis of functional neurological symptom disorder is supported by the presence of multiple functional voice disorder symptoms and subtypes (evidence of internal inconsistency); the diagnosis is confirmed by normal vocal cord movement on laryngoscopy.</p><p>Patients with functional motor symptoms also commonly complain of intermittent slurred speech; other articulatory and prosodic speech problems may be characteristic of functional neurological symptom disorder, including stuttering speech and telegrammatic speech (omitting conjunctions and definite articles) [<a href="#rid53">53-55</a>]. Foreign accent syndrome and mutism may also occur as a functional neurological symptom disorder [<a href="#rid54">54,56</a>].</p><p class="headingAnchor" id="H13158901"><span class="h3">Globus sensation (swallowing symptoms)</span><span class="headingEndMark"> — </span>Globus sensation (also called globus pharyngeus) describes the functional symptom of a “lump” or “ball” in the throat [<a href="#rid57">57</a>]. The sensation is usually most pronounced at times other than during swallowing. Globus pharyngeus is discussed separately. (See  <a class="medical medical_review" href="/d/html/2240.html" rel="external">"Globus sensation"</a>.)</p><p class="headingAnchor" id="H13158908"><span class="h3">Sensory symptoms</span><span class="headingEndMark"> — </span>Sensory disturbance (eg, anesthesia or sensory loss) is common in functional neurological symptom disorder; a randomized trial with 127 patients found that paresthesias occurred in 50 percent and numbness in 41 percent [<a href="#rid17">17</a>]. In addition, patients often report a feeling of being “cut in half” (midline splitting) or that one side or part of their body “doesn’t belong” to them, and may report a mixture of pain, sensory disturbance, and weakness [<a href="#rid14">14</a>].</p><p>Sensory symptoms in functional neurological symptom disorder may be incongruent with known nerve pathways. As an example, patients may describe sensory loss in the entire arm with a circumferential cut off at the shoulder, or the whole leg with a circumferential cut off at the groin, which is incompatible with dermatomal or cortical sensory loss [<a href="#rid8">8,58</a>].</p><p>There are several physical signs that suggest a diagnosis of functional sensory loss, but none are conclusive because the signs are not specific to functional neurological symptom disorder, patients may misunderstand the clinician’s instructions, and the signs can be found in patients with sensory problems due to neurologic disease with a known pathologic basis [<a href="#rid59">59</a>]. These signs include [<a href="#rid8">8,14,41</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Altered vibration sense across the forehead or sternum (which generally should not occur in recognizable disease because these are single bones)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Midline splitting (<a class="graphic graphic_figure graphicRef88077" href="/d/graphic/88077.html" rel="external">figure 3</a>), in which sensation is split exactly in the midline (cutaneous branches of the intercostal nerves overlap such that sensory loss should occur 1 to 2 centimeters from the midline; however, midline splitting can occur in thalamic stroke)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients with complete sensory loss who respond when they are asked to say “yes” if they feel a stimulus and “no” if they do not</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Inconsistent responses when sensation in the hands is tested with the fingers interlocked behind the back</p><p></p><p class="headingAnchor" id="H13158915"><span class="h4">Visual symptoms</span><span class="headingEndMark"> — </span>Functional visual disturbance is common; a randomized trial with 127 patients found that functional visual symptoms occurred in 16 percent [<a href="#rid17">17</a>]. Functional visual symptoms include intermittent blurred vision, double vision (due to spasm of convergent eye movements), nystagmus, visual field defects, and complete blindness [<a href="#rid8">8</a>].</p><p>Complete blindness, as with complete paralysis, is associated with an increased probability that the symptom is factitious. In patients with complete binocular blindness, specific tests for functional neurological symptom disorder with visual symptoms include the following [<a href="#rid8">8,60</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Fingertip test, which is performed by asking the patient to touch the tips of their index fingers together. Whereas blind people can readily do so using proprioception, patients with functional neurological symptom disorder tend to have difficulty bringing their fingers together.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Signature test, which is a nonvisual task that blind people can perform. Patients with functional neurological symptom disorder may have difficulty writing their signature.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Menace reflex, which involves presenting a visual threat (eg, a rapidly approaching hand) to the eye. Flinching or blinking is generally observed in functional neurological symptom disorder. This test does not exclude a cortical visual problem.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Tearing reflex, which consists of tearing in response to suddenly presenting strong illumination in front of the patient; the reflex requires intact vision. This test does not exclude a cortical visual problem.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Optokinetic test, which consists of holding a large rotating drum with black and white vertical stripes on it close to the patient’s eyes. Optokinetic nystagmus indicates that at some level the brain can detect the stripes; however, this test does not exclude a cortical visual problem.</p><p></p><p>Other tests for functional visual symptoms include the following [<a href="#rid8">8,60</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Tubular visual field defect; as an example, tunnel vision of the same width when the patients is examined at 1 and 2 meters (<a class="graphic graphic_figure graphicRef88074" href="/d/graphic/88074.html" rel="external">figure 4</a>).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Convergence spasm leading to hyperadduction of one eye during convergent testing, which can resemble a sixth nerve palsy. The patient may also complain of diplopia [<a href="#rid61">61</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A pattern of “spiraling” on Goldmann automated visual field testing. This occurs because at the start of an automated visual test, peripheral vision is present. However, as the test progresses and the stimuli rotate, the patient typically develops increasing “tunnel vision” resulting in a “spiral.”</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Fogging test of reduced visual acuity – Lenses of increasing diopter are placed over the patient’s unaffected eye (without the patient’s awareness) while reading a Snellen chart until any remaining acuity must be coming from the affected eye.</p><p></p><p class="headingAnchor" id="H173788195"><span class="h4">Other special sensory symptoms</span><span class="headingEndMark"> — </span>Functional symptoms may rarely take the form of olfactory or hearing disturbances [<a href="#rid1">1</a>].</p><p class="headingAnchor" id="H13158922"><span class="h3">Cognitive symptoms</span><span class="headingEndMark"> — </span>Cognitive symptoms are not usually described as part of functional neurological symptom disorder [<a href="#rid1">1</a>]. Nevertheless, a functional cognitive disorder can be diagnosed if there are positive clinical findings that demonstrate either inconsistency at different points in the examination, or incongruity between the symptoms and recognized disease [<a href="#rid62">62-64</a>] (see <a class="local">'Examination'</a> above). Cognitive symptoms that are commonly encountered in patients with functional neurological symptom disorder include [<a href="#rid65">65,66</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Poor concentration and memory</p><p class="bulletIndent1"><span class="glyph">●</span>Impaired fluency</p><p class="bulletIndent1"><span class="glyph">●</span>Jumbling of words when speaking</p><p class="bulletIndent1"><span class="glyph">●</span>Word finding difficulty</p><p class="bulletIndent1"><span class="glyph">●</span>Variability in speed of response</p><p></p><p>More marked cognitive symptoms may occur in bedside tests of cognition and on neuropsychological testing [<a href="#rid62">62,63</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Marked loss of remote autobiographical memory</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Inability to perform overlearned skills such as reading, spelling, or simple arithmetic</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Ability to perform complex implicit cognitive tasks in the presence of poor performance on simple explicit tasks</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Performance inconsistent with observed behavior</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Performance inconsistent at different points in the examination or across repeated evaluations</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Impaired performance on tests of effort specifically designed to assess validity of cognitive performance (although poor performance on these tests does not distinguish between intentional and unintentional poor performance)</p><p></p><p>Some of these symptoms may also be attributable to anxiety or depressive disorders.</p><p>More dramatic amnesia may occur as a symptom of functional neurological symptom disorder [<a href="#rid67">67</a>]. Short periods of amnesia are integral to functional seizures (during which the patient is unresponsive and amnesic for events rather than unconscious) and may also accompany the onset of motor functional symptoms. Isolated functional amnesia presents with a dense and well demarcated focal retrograde memory loss for a period ranging from days to years with preservation of anterograde memory function (ability to make new memories) [<a href="#rid68">68</a>].</p><p class="headingAnchor" id="H7903844"><span class="h2">Laboratory and radiologic studies</span><span class="headingEndMark"> — </span>Laboratory, radiologic, and neurophysiologic tests are generally required to seek neurologic/general medical disorders that either explain the presenting symptoms or are comorbid [<a href="#rid21">21</a>]. However, the diagnosis of functional neurological symptom disorder is not one of exclusion and rests upon positive clinical findings, rather than negative tests. Although negative test results are consistent with the diagnosis in most patients with functional neurological symptom disorder, many patients with neurologic disorders have normal test results, and a diagnosis of functional neurological symptom disorder can still be made when an additional neurologic disease is present (as long as that disease is not a better explanation for the examination findings) [<a href="#rid11">11,40,69</a>].</p><p>Investigations should be performed as quickly as possible; protracted testing may encourage diagnostic uncertainty in patients, who then focus upon finding a disease rather than rehabilitation [<a href="#rid8">8</a>]. We are explicit about why we are ordering the tests, and predict the results will be normal when this is reasonable [<a href="#rid14">14</a>].</p><p>We warn patients that testing may uncover abnormalities that are unrelated to the presenting symptoms (but which derail treating the symptoms). As an example, a meta-analysis of 16 studies with more than 19,000 individuals found that incidental findings occur in approximately 3 percent of brain magnetic resonance images [<a href="#rid70">70</a>]. In addition, spinal imaging of asymptomatic individuals shows disc prolapses at a frequency percentage roughly equal to the patients “age plus 10” [<a href="#rid71">71</a>]. Tests can also yield false negatives.</p><p class="headingAnchor" id="H13158929"><span class="h1">COMORBID DISORDERS</span><span class="headingEndMark"> — </span>Comorbidity is common in functional neurological symptom disorder (conversion disorder), and patients may have multiple comorbid disorders.</p><p class="headingAnchor" id="H13158936"><span class="h2">Psychiatric disorders</span><span class="headingEndMark"> — </span>Comorbid psychiatric disorders may occur in up to 90 percent or more of patients with functional neurological symptom disorder [<a href="#rid15">15,16,72-74</a>]. As an example, a prospective study found that the lifetime prevalence of psychiatric disorders was greater in patients with functional weakness (n = 107) than patients with weakness due to recognizable neurologic disease (n = 46; 95 versus 71 percent of patients) [<a href="#rid21">21</a>].</p><p>Multiple studies suggest that the frequency of comorbid depressive disorders and anxiety disorders in patients with functional neurological symptom disorder exceeds the frequency in patients with defined neurologic disease by approximately 20 to 30 percent [<a href="#rid18">18,75,76</a>]. As an example, a prospective study found higher rates of comorbid depression and/or anxiety in patients with functional weakness (n = 107) compared with patients with weakness due to a neurologic disease such as multiple sclerosis (n = 46) [<a href="#rid21">21</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Unipolar major depression – 32 versus 7 percent</p><p class="bulletIndent1"><span class="glyph">●</span>Generalized anxiety disorder – 21 versus 2 percent</p><p class="bulletIndent1"><span class="glyph">●</span>Panic disorder – 36 versus 13 percent</p><p></p><p>Dissociative disorders are also common in patients with functional neurological symptom disorder. A prospective study of 38 patients found a dissociative disorder in 47 percent [<a href="#rid74">74</a>].</p><p>Compared with patients who have defined neurologic disease, patients with functional neurological symptom disorder are more likely to have personality disorders, especially [<a href="#rid15">15,73,77</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Borderline personality disorder</p><p class="bulletIndent1"><span class="glyph">●</span>Histrionic personality disorder</p><p class="bulletIndent1"><span class="glyph">●</span>Narcissistic personality disorder</p><p></p><p>As an example, a prospective study found that a comorbid personality disorder was present in more patients with functional neurological symptom disorder (n = 30) than patients with recognizable neurologic disease (n = 30; 50 versus 17 percent) [<a href="#rid18">18</a>].</p><p>Suicide attempts occur often in functional neurological symptom disorder. A prospective study of 38 patients found a history of suicide attempts in 34 percent [<a href="#rid74">74</a>].</p><p>Psychotic disorders and substance use disorders do not appear to be associated with functional neurological symptom disorder [<a href="#rid6">6,75</a>].</p><p class="headingAnchor" id="H13158943"><span class="h2">Neurologic and general medical disorders</span><span class="headingEndMark"> — </span>A current or prior neurologic disorder may be found in many patients with functional neurological symptom disorder [<a href="#rid1">1</a>]. The presence of neurologic or other general medical disorders do not preclude a diagnosis of functional neurological symptom disorder if the functional symptoms are not fully explained by the general medical disorder [<a href="#rid10">10</a>]. The differential diagnosis of functional neurological symptom disorder, including neurologic and general medical disorders, is discussed separately. (See  <a class="medical medical_review" href="/d/html/14826.html" rel="external">"Functional neurological symptom disorder (conversion disorder) in adults: Terminology, diagnosis, and differential diagnosis", section on 'Neurologic disorders'</a>.)</p><p class="headingAnchor" id="H13157954"><span class="h1">SUMMARY</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Subtypes and their clinical features</strong> – Functional neurological symptom disorder (conversion disorder) can present with different symptoms, such as:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Nonepileptic seizures</p><p class="bulletIndent2"><span class="glyph">•</span>Weakness and paralysis</p><p class="bulletIndent2"><span class="glyph">•</span>Abnormal movement</p><p class="bulletIndent2"><span class="glyph">•</span>Speech disturbances</p><p class="bulletIndent2"><span class="glyph">•</span>Globus sensation (swallowing symptoms)</p><p class="bulletIndent2"><span class="glyph">•</span>Sensory symptoms</p><p class="bulletIndent2"><span class="glyph">•</span>Visual symptoms</p><p class="bulletIndent2"><span class="glyph">•</span>Cognitive symptoms</p><p></p><p class="bulletIndent1">(See <a class="local">'General principles'</a> above and <a class="local">'Subtypes of functional neurological symptom disorder'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Assessment</strong> – Assessment of patients presenting with possible functional neurological symptom disorder includes a medical history, physical examination, and indicated laboratory tests, as well as the psychiatric history and mental status examination. It is essential to look for neurologic and other general medical conditions, particularly early-stage disease. (See <a class="local">'General principles'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>History</strong> – Clinicians taking the initial history of patients with a possible diagnosis of functional neurological symptom disorder should ask about all current somatic symptoms; the circumstances at onset of functional symptoms; dissociation; disability; ideas, concerns and expectations; psychosocial functioning; family history; course of illness; previous functional disorders and functional symptoms; prior clinical experiences; recent psychological stressors; and symptoms of comorbid psychiatric disorders. Questions about physical and sexual abuse are often best deferred until trust has been established. (See <a class="local">'History'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Examination</strong> – For patients who present with symptoms that may indicate a functional neurological symptom disorder, clinicians should look for evidence of inconsistency at different points in the examination as well as incongruity between symptoms and recognized disease. (See <a class="local">'Examination'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Laboratory and radiologic tests</strong> – Laboratory and radiologic tests are generally required to seek neurologic/general medical disorders that either explain the presenting symptoms or are comorbid. (See <a class="local">'Laboratory and radiologic studies'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Comorbid psychiatric disorders</strong> – In patients with functional neurological symptom disorder, the prevalence of comorbid psychiatric disorders, especially depressive, anxiety, dissociative, and personality disorders, exceeds that found in defined neurologic diseases. (See <a class="local">'Psychiatric disorders'</a> above.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li class="breakAll">American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR), Washington, DC 2022.</li><li><a class="nounderline abstract_t">Stone J, Carson A, Duncan R, et al. Who is referred to neurology clinics?--the diagnoses made in 3781 new patients. Clin Neurol Neurosurg 2010; 112:747.</a></li><li><a class="nounderline abstract_t">Carson A, Stone J, Hibberd C, et al. Disability, distress and unemployment in neurology outpatients with symptoms 'unexplained by organic disease'. J Neurol Neurosurg Psychiatry 2011; 82:810.</a></li><li><a class="nounderline abstract_t">Gelauff J, Stone J, Edwards M, Carson A. The prognosis of functional (psychogenic) motor symptoms: a systematic review. J Neurol Neurosurg Psychiatry 2014; 85:220.</a></li><li><a class="nounderline abstract_t">Durrant J, Rickards H, Cavanna AE. Prognosis and outcome predictors in psychogenic nonepileptic seizures. Epilepsy Res Treat 2011; 2011:274736.</a></li><li><a class="nounderline abstract_t">Rosebush PI, Mazurek MF. Treatment of conversion disorder in the 21st century: have we moved beyond the couch? Curr Treat Options Neurol 2011; 13:255.</a></li><li><a class="nounderline abstract_t">Stone J, Vuilleumier P, Friedman JH. Conversion disorder: separating "how" from "why". Neurology 2010; 74:190.</a></li><li><a class="nounderline abstract_t">Stone J, Carson A, Sharpe M. Functional symptoms and signs in neurology: assessment and diagnosis. J Neurol Neurosurg Psychiatry 2005; 76 Suppl 1:i2.</a></li><li class="breakAll">Abbey SE, Wulsin L, Levenson JL. Somatization and somatoform disorders. In: The American Psychiatric Publishing Textbook of Psychosomatic Medicine: Psychiatric Care of the Medically Ill, Second Edition, Levenson JL (Ed), American Psychiatric Publishing, Inc., Washington, DC 2011. p.261.</li><li><a class="nounderline abstract_t">Stone J, Reuber M, Carson A. Functional symptoms in neurology: mimics and chameleons. Pract Neurol 2013; 13:104.</a></li><li><a class="nounderline abstract_t">Kutlubaev MA, Xu Y, Hackett ML, Stone J. Dual diagnosis of epilepsy and psychogenic nonepileptic seizures: Systematic review and meta-analysis of frequency, correlates, and outcomes. Epilepsy Behav 2018; 89:70.</a></li><li><a class="nounderline abstract_t">Stone J, Carson A, Duncan R, et al. Which neurological diseases are most likely to be associated with "symptoms unexplained by organic disease". J Neurol 2012; 259:33.</a></li><li><a class="nounderline abstract_t">Stonnington CM, Barry JJ, Fisher RS. Conversion disorder. Am J Psychiatry 2006; 163:1510.</a></li><li><a class="nounderline abstract_t">Stone J. The bare essentials: Functional symptoms in neurology. Pract Neurol 2009; 9:179.</a></li><li><a class="nounderline abstract_t">Crimlisk HL, Bhatia K, Cope H, et al. Slater revisited: 6 year follow up study of patients with medically unexplained motor symptoms. BMJ 1998; 316:582.</a></li><li><a class="nounderline abstract_t">Roelofs K, Spinhoven P, Sandijck P, et al. The impact of early trauma and recent life-events on symptom severity in patients with conversion disorder. J Nerv Ment Dis 2005; 193:508.</a></li><li><a class="nounderline abstract_t">Sharpe M, Walker J, Williams C, et al. Guided self-help for functional (psychogenic) symptoms: a randomized controlled efficacy trial. Neurology 2011; 77:564.</a></li><li><a class="nounderline abstract_t">Binzer M, Andersen PM, Kullgren G. Clinical characteristics of patients with motor disability due to conversion disorder: a prospective control group study. J Neurol Neurosurg Psychiatry 1997; 63:83.</a></li><li><a class="nounderline abstract_t">Stone J, Carson A, Sharpe M. Functional symptoms in neurology: management. J Neurol Neurosurg Psychiatry 2005; 76 Suppl 1:i13.</a></li><li><a class="nounderline abstract_t">Stone J, Sharpe M, Rothwell PM, Warlow CP. The 12 year prognosis of unilateral functional weakness and sensory disturbance. J Neurol Neurosurg Psychiatry 2003; 74:591.</a></li><li><a class="nounderline abstract_t">Stone J, Warlow C, Sharpe M. The symptom of functional weakness: a controlled study of 107 patients. Brain 2010; 133:1537.</a></li><li><a class="nounderline abstract_t">Stone J, Carson A, Aditya H, et al. The role of physical injury in motor and sensory conversion symptoms: a systematic and narrative review. J Psychosom Res 2009; 66:383.</a></li><li><a class="nounderline abstract_t">van Rooijen DE, Geraedts EJ, Marinus J, et al. Peripheral trauma and movement disorders: a systematic review of reported cases. J Neurol Neurosurg Psychiatry 2011; 82:892.</a></li><li><a class="nounderline abstract_t">Pareés I, Kojovic M, Pires C, et al. Physical precipitating factors in functional movement disorders. J Neurol Sci 2014; 338:174.</a></li><li><a class="nounderline abstract_t">Stone J, Warlow C, Sharpe M. Functional weakness: clues to mechanism from the nature of onset. J Neurol Neurosurg Psychiatry 2012; 83:67.</a></li><li><a class="nounderline abstract_t">Reuber M, Enright SM, Goulding PJ. Postoperative pseudostatus: not everything that shakes is epilepsy. Anaesthesia 2000; 55:74.</a></li><li><a class="nounderline abstract_t">Brown RJ, Cardeña E, Nijenhuis E, et al. Should conversion disorder be reclassified as a dissociative disorder in DSM V? Psychosomatics 2007; 48:369.</a></li><li><a class="nounderline abstract_t">Lyssenko L, Schmahl C, Bockhacker L, et al. Dissociation in Psychiatric Disorders: A Meta-Analysis of Studies Using the Dissociative Experiences Scale. Am J Psychiatry 2018; 175:37.</a></li><li><a class="nounderline abstract_t">Stone J, Binzer M, Sharpe M. Illness beliefs and locus of control: a comparison of patients with pseudoseizures and epilepsy. J Psychosom Res 2004; 57:541.</a></li><li><a class="nounderline abstract_t">Nielsen G, Buszewicz M, Edwards MJ, Stevenson F. A qualitative study of the experiences and perceptions of patients with functional motor disorder. Disabil Rehabil 2020; 42:2043.</a></li><li><a class="nounderline abstract_t">Rawlings GH, Reuber M. What patients say about living with psychogenic nonepileptic seizures: A systematic synthesis of qualitative studies. Seizure 2016; 41:100.</a></li><li><a class="nounderline abstract_t">Stamelou M, Cossu G, Edwards MJ, et al. Familial psychogenic movement disorders. Mov Disord 2013; 28:1295.</a></li><li><a class="nounderline abstract_t">Stone J, Warlow C, Deary I, Sharpe M. Predisposing Risk Factors for Functional Limb Weakness: A Case-Control Study. J Neuropsychiatry Clin Neurosci 2020; 32:50.</a></li><li><a class="nounderline abstract_t">Nicholson TR, Aybek S, Craig T, et al. Life events and escape in conversion disorder. Psychol Med 2016; 46:2617.</a></li><li><a class="nounderline abstract_t">Ludwig L, Pasman JA, Nicholson T, et al. Stressful life events and maltreatment in conversion (functional neurological) disorder: systematic review and meta-analysis of case-control studies. Lancet Psychiatry 2018; 5:307.</a></li><li><a class="nounderline abstract_t">Kranick S, Ekanayake V, Martinez V, et al. Psychopathology and psychogenic movement disorders. Mov Disord 2011; 26:1844.</a></li><li><a class="nounderline abstract_t">Carson AJ, Brown R, David AS, et al. Functional (conversion) neurological symptoms: research since the millennium. J Neurol Neurosurg Psychiatry 2012; 83:842.</a></li><li><a class="nounderline abstract_t">Stone J, Sharpe M, Carson A, et al. Are functional motor and sensory symptoms really more frequent on the left? A systematic review. J Neurol Neurosurg Psychiatry 2002; 73:578.</a></li><li><a class="nounderline abstract_t">Stone J, Smyth R, Carson A, et al. La belle indifférence in conversion symptoms and hysteria: systematic review. Br J Psychiatry 2006; 188:204.</a></li><li><a class="nounderline abstract_t">Wissel BD, Dwivedi AK, Merola A, et al. Functional neurological disorders in Parkinson disease. J Neurol Neurosurg Psychiatry 2018; 89:566.</a></li><li><a class="nounderline abstract_t">Daum C, Hubschmid M, Aybek S. The value of 'positive' clinical signs for weakness, sensory and gait disorders in conversion disorder: a systematic and narrative review. J Neurol Neurosurg Psychiatry 2014; 85:180.</a></li><li><a class="nounderline abstract_t">Ziv I, Djaldetti R, Zoldan Y, et al. Diagnosis of "non-organic" limb paresis by a novel objective motor assessment: the quantitative Hoover's test. J Neurol 1998; 245:797.</a></li><li><a class="nounderline abstract_t">Diukova GM, Ljachovetckaja NI, Begljarova MA, Gavrileyko GI. Simple quantitative analysis of Hoover's test in patients with psychogenic and organic limb pareses. J Psychosom Res 2013; 74:361.</a></li><li><a class="nounderline abstract_t">McWhirter L, Stone J, Sandercock P, Whiteley W. Hoover's sign for the diagnosis of functional weakness: a prospective unblinded cohort study in patients with suspected stroke. J Psychosom Res 2011; 71:384.</a></li><li><a class="nounderline abstract_t">Daum C, Gheorghita F, Spatola M, et al. Interobserver agreement and validity of bedside 'positive signs' for functional weakness, sensory and gait disorders in conversion disorder: a pilot study. J Neurol Neurosurg Psychiatry 2015; 86:425.</a></li><li><a class="nounderline abstract_t">Sonoo M. Abductor sign: a reliable new sign to detect unilateral non-organic paresis of the lower limb. J Neurol Neurosurg Psychiatry 2004; 75:121.</a></li><li><a class="nounderline abstract_t">Stone J, Zeman A, Sharpe M. Functional weakness and sensory disturbance. J Neurol Neurosurg Psychiatry 2002; 73:241.</a></li><li><a class="nounderline abstract_t">Fasano A, Valadas A, Bhatia KP, et al. Psychogenic facial movement disorders: clinical features and associated conditions. Mov Disord 2012; 27:1544.</a></li><li><a class="nounderline abstract_t">Kaski D, Bronstein AM, Edwards MJ, Stone J. Cranial functional (psychogenic) movement disorders. Lancet Neurol 2015; 14:1196.</a></li><li><a class="nounderline abstract_t">Daum C, Aybek S. Validity of the "Drift without pronation" sign in conversion disorder. BMC Neurol 2013; 13:31.</a></li><li><a class="nounderline abstract_t">Horn D, Galli S, Berney A, et al. Testing Head Rotation and Flexion Is Useful in Functional Limb Weakness. Mov Disord Clin Pract 2017; 4:597.</a></li><li><a class="nounderline abstract_t">Baker J. Functional voice disorders: Clinical presentations and differential diagnosis. Handb Clin Neurol 2016; 139:389.</a></li><li><a class="nounderline abstract_t">Binder LM, Spector J, Youngjohn JR. Psychogenic stuttering and other acquired nonorganic speech and language abnormalities. Arch Clin Neuropsychol 2012; 27:557.</a></li><li><a class="nounderline abstract_t">Baizabal-Carvallo JF, Jankovic J. Speech and voice disorders in patients with psychogenic movement disorders. J Neurol 2015; 262:2420.</a></li><li><a class="nounderline abstract_t">Duffy JR. Functional speech disorders: clinical manifestations, diagnosis, and management. Handb Clin Neurol 2016; 139:379.</a></li><li><a class="nounderline abstract_t">McWhirter L, Miller N, Campbell C, et al. Understanding foreign accent syndrome. J Neurol Neurosurg Psychiatry 2019; 90:1265.</a></li><li><a class="nounderline abstract_t">Selleslagh M, van Oudenhove L, Pauwels A, et al. The complexity of globus: a multidisciplinary perspective. Nat Rev Gastroenterol Hepatol 2014; 11:220.</a></li><li><a class="nounderline abstract_t">Stone J, Vermeulen M. Functional sensory symptoms. Handb Clin Neurol 2016; 139:271.</a></li><li><a class="nounderline abstract_t">Rolak LA. Psychogenic sensory loss. J Nerv Ment Dis 1988; 176:686.</a></li><li><a class="nounderline abstract_t">Chen CS, Lee AW, Karagiannis A, et al. Practical clinical approaches to functional visual loss. J Clin Neurosci 2007; 14:1.</a></li><li><a class="nounderline abstract_t">Fekete R, Baizabal-Carvallo JF, Ha AD, et al. Convergence spasm in conversion disorders: prevalence in psychogenic and other movement disorders compared with controls. J Neurol Neurosurg Psychiatry 2012; 83:202.</a></li><li><a class="nounderline abstract_t">Delis DC, Wetter SR. Cogniform Disorder and Cogniform Condition: proposed diagnoses for excessive cognitive symptoms. Arch Clin Neuropsychol 2007; 22:589.</a></li><li><a class="nounderline abstract_t">Jones D, Drew P, Elsey C, et al. Conversational assessment in memory clinic encounters: interactional profiling for differentiating dementia from functional memory disorders. Aging Ment Health 2016; 20:500.</a></li><li><a class="nounderline abstract_t">McWhirter L, Ritchie C, Stone J, Carson A. Functional cognitive disorders: a systematic review. Lancet Psychiatry 2020; 7:191.</a></li><li><a class="nounderline abstract_t">Pennington C, Newson M, Hayre A, Coulthard E. Functional cognitive disorder: what is it and what to do about it? Pract Neurol 2015; 15:436.</a></li><li><a class="nounderline abstract_t">Stone J, Pal S, Blackburn D, et al. Functional (Psychogenic) Cognitive Disorders: A Perspective from the Neurology Clinic. J Alzheimers Dis 2015; 48 Suppl 1:S5.</a></li><li><a class="nounderline abstract_t">Harrison NA, Johnston K, Corno F, et al. Psychogenic amnesia: syndromes, outcome, and patterns of retrograde amnesia. Brain 2017; 140:2498.</a></li><li><a class="nounderline abstract_t">Staniloiu A, Markowitsch HJ. Dissociative amnesia. Lancet Psychiatry 2014; 1:226.</a></li><li class="breakAll">Carson AJ, Zeman A, Stone J, Sharpe MC. Neurology and neurosurgery. In: The American Psychiatric Publishing Textbook of Psychosomatic Medicine: Psychiatric Care of the Medically Ill, Second Edition, Levenson JL (Ed), American Psychiatric Publishing, Inc., Washington, DC 2011. p.759.</li><li><a class="nounderline abstract_t">Morris Z, Whiteley WN, Longstreth WT Jr, et al. Incidental findings on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ 2009; 339:b3016.</a></li><li><a class="nounderline abstract_t">Brinjikji W, Luetmer PH, Comstock B, et al. Systematic literature review of imaging features of spinal degeneration in asymptomatic populations. AJNR Am J Neuroradiol 2015; 36:811.</a></li><li><a class="nounderline abstract_t">Lempert T, Schmidt D. Natural history and outcome of psychogenic seizures: a clinical study in 50 patients. J Neurol 1990; 237:35.</a></li><li class="breakAll">Fiszman A, Kanner AM. Comorbidities in psychogenic nonepileptic seizures: Depressive, anxiety, and personality disorders. In: Gates and Rowan's Nonepileptic Seizures, 3rd ed., Schacter S, LaFrance Jr WC (Eds), Cambridge University Press, Cambridge 2010. p.225.</li><li><a class="nounderline abstract_t">Sar V, Akyüz G, Kundakçi T, et al. Childhood trauma, dissociation, and psychiatric comorbidity in patients with conversion disorder. Am J Psychiatry 2004; 161:2271.</a></li><li><a class="nounderline abstract_t">Schrag A, Trimble M, Quinn N, Bhatia K. The syndrome of fixed dystonia: an evaluation of 103 patients. Brain 2004; 127:2360.</a></li><li><a class="nounderline abstract_t">Brown RJ, Reuber M. Psychological and psychiatric aspects of psychogenic non-epileptic seizures (PNES): A systematic review. Clin Psychol Rev 2016; 45:157.</a></li><li><a class="nounderline abstract_t">Stone J, Sharpe M, Binzer M. Motor conversion symptoms and pseudoseizures: a comparison of clinical characteristics. Psychosomatics 2004; 45:492.</a></li></ol></div><div id="topicVersionRevision">Topic 85765 Version 20.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="javascript:alert('بدون لینک');" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR), Washington, DC 2022.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20646830" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Who is referred to neurology clinics?--the diagnoses made in 3781 new patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21257981" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Disability, distress and unemployment in neurology outpatients with symptoms 'unexplained by organic disease'.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24029543" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : The prognosis of functional (psychogenic) motor symptoms: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22937230" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Prognosis and outcome predictors in psychogenic nonepileptic seizures.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21468672" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Treatment of conversion disorder in the 21st century: have we moved beyond the couch?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20083794" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Conversion disorder: separating "how" from "why".</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15718217" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Functional symptoms and signs in neurology: assessment and diagnosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15718217" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Functional symptoms and signs in neurology: assessment and diagnosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23468561" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Functional symptoms in neurology: mimics and chameleons.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30384103" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Dual diagnosis of epilepsy and psychogenic nonepileptic seizures: Systematic review and meta-analysis of frequency, correlates, and outcomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21674198" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Which neurological diseases are most likely to be associated with "symptoms unexplained by organic disease".</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16946174" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Conversion disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19448064" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : The bare essentials: Functional symptoms in neurology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9518908" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Slater revisited: 6 year follow up study of patients with medically unexplained motor symptoms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16082294" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : The impact of early trauma and recent life-events on symptom severity in patients with conversion disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21795652" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Guided self-help for functional (psychogenic) symptoms: a randomized controlled efficacy trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9221972" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Clinical characteristics of patients with motor disability due to conversion disorder: a prospective control group study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15718216" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Functional symptoms in neurology: management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12700300" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : The 12 year prognosis of unilateral functional weakness and sensory disturbance.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20395262" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : The symptom of functional weakness: a controlled study of 107 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19379954" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : The role of physical injury in motor and sensory conversion symptoms: a systematic and narrative review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21493756" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Peripheral trauma and movement disorders: a systematic review of reported cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24439198" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Physical precipitating factors in functional movement disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21836030" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Functional weakness: clues to mechanism from the nature of onset.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10594435" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Postoperative pseudostatus: not everything that shakes is epilepsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17878494" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Should conversion disorder be reclassified as a dissociative disorder in DSM V?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28946763" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Dissociation in Psychiatric Disorders: A Meta-Analysis of Studies Using the Dissociative Experiences Scale.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15596160" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Illness beliefs and locus of control: a comparison of patients with pseudoseizures and epilepsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30669889" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : A qualitative study of the experiences and perceptions of patients with functional motor disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27522576" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : What patients say about living with psychogenic nonepileptic seizures: A systematic synthesis of qualitative studies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23568243" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Familial psychogenic movement disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31466514" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Predisposing Risk Factors for Functional Limb Weakness: A Case-Control Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27377290" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Life events and escape in conversion disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29526521" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Stressful life events and maltreatment in conversion (functional neurological) disorder: systematic review and meta-analysis of case-control studies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21714007" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Psychopathology and psychogenic movement disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22661497" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Functional (conversion) neurological symptoms: research since the millennium.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12397155" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Are functional motor and sensory symptoms really more frequent on the left? A systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16507959" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : La belle indifférence in conversion symptoms and hysteria: systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29549192" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Functional neurological disorders in Parkinson disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23467417" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : The value of 'positive' clinical signs for weakness, sensory and gait disorders in conversion disorder: a systematic and narrative review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9840352" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Diagnosis of "non-organic" limb paresis by a novel objective motor assessment: the quantitative Hoover's test.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23497840" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Simple quantitative analysis of Hoover's test in patients with psychogenic and organic limb pareses.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22118379" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Hoover's sign for the diagnosis of functional weakness: a prospective unblinded cohort study in patients with suspected stroke.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24994927" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Interobserver agreement and validity of bedside 'positive signs' for functional weakness, sensory and gait disorders in conversion disorder: a pilot study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14707320" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Abductor sign: a reliable new sign to detect unilateral non-organic paresis of the lower limb.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12185152" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Functional weakness and sensory disturbance.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23033125" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Psychogenic facial movement disorders: clinical features and associated conditions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26581970" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Cranial functional (psychogenic) movement disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23548051" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Validity of the "Drift without pronation" sign in conversion disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30363481" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Testing Head Rotation and Flexion Is Useful in Functional Limb Weakness.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27719859" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Functional voice disorders: Clinical presentations and differential diagnosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22789718" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Psychogenic stuttering and other acquired nonorganic speech and language abnormalities.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26194199" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Speech and voice disorders in patients with psychogenic movement disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27719858" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Functional speech disorders: clinical manifestations, diagnosis, and management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30826739" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Understanding foreign accent syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24296583" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : The complexity of globus: a multidisciplinary perspective.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27719847" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Functional sensory symptoms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3183653" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Psychogenic sensory loss.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16730991" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Practical clinical approaches to functional visual loss.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21949106" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Convergence spasm in conversion disorders: prevalence in psychogenic and other movement disorders compared with controls.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17485192" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Cogniform Disorder and Cogniform Condition: proposed diagnoses for excessive cognitive symptoms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25803169" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Conversational assessment in memory clinic encounters: interactional profiling for differentiating dementia from functional memory disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31732482" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Functional cognitive disorders: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26271265" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Functional cognitive disorder: what is it and what to do about it?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26445274" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Functional (Psychogenic) Cognitive Disorders: A Perspective from the Neurology Clinic.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29050391" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Psychogenic amnesia: syndromes, outcome, and patterns of retrograde amnesia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26360734" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Dissociative amnesia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26360734" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Dissociative amnesia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19687093" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Incidental findings on brain magnetic resonance imaging: systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25430861" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Systematic literature review of imaging features of spinal degeneration in asymptomatic populations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2319265" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Natural history and outcome of psychogenic seizures: a clinical study in 50 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2319265" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Natural history and outcome of psychogenic seizures: a clinical study in 50 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15569899" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Childhood trauma, dissociation, and psychiatric comorbidity in patients with conversion disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15342362" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : The syndrome of fixed dystonia: an evaluation of 103 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27084446" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Psychological and psychiatric aspects of psychogenic non-epileptic seizures (PNES): A systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15546826" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Motor conversion symptoms and pseudoseizures: a comparison of clinical characteristics.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
